1. AASLD-IDSA. HCV guidance: Recommendations for testing, managing, and treating hepatitis C. Retrieved July 22, 2019 from
https://www.hcvguidelines.org/sites/default/files/full-guidance-pdf/HCVGuidance_May_24_2018b.pdf
2. Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y., Holtzman, D., & Ward, J. W. (2012). Hepatitis C virus testing of persons born during 1945-1965: Recommendations from the Centers for Disease Control and Prevention. Annals of Internal Medicine,157, 817–822.
https://doi.org/10.7326/0003-4819-157-9-201211060-00529
.
3. Yehia, B. R., Schranz, A. J., Umscheid, C. A., Lo Re, I. I. I., & Lo Re III, V. (2014). The treatment cascade for chronic Hepatitis C Virus infection in the United States: A systematic review and meta-analysis. PLoS ONE,9(7), 1–7.
4. Kattakuzhy, S., Gross, C., Emmanuel, B., et al. (2017). Expansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providers: A nonrandomized clinical trial. Annals of Internal Medicine,167(5), 311–318.
5. Gardner, E. M., McLees, M. P., Steiner, J. T., Del Rio, C., & Burman, W. J. (2011). The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clinical Infectious Diseases,52(6), 793–800.